INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,741,000 | -46.6% | 110,267 | -49.9% | 0.00% | -55.6% |
Q4 2020 | $7,003,000 | +19.5% | 220,234 | -3.5% | 0.01% | 0.0% |
Q3 2020 | $5,859,000 | +7.5% | 228,334 | +7.6% | 0.01% | 0.0% |
Q2 2020 | $5,448,000 | +50.2% | 212,224 | -10.0% | 0.01% | +12.5% |
Q1 2020 | $3,626,000 | -28.0% | 235,924 | +60.7% | 0.01% | -11.1% |
Q4 2019 | $5,038,000 | +130.9% | 146,824 | -49.7% | 0.01% | +350.0% |
Q3 2019 | $2,182,000 | +22.2% | 292,048 | +112.4% | 0.00% | -50.0% |
Q2 2019 | $1,785,000 | +4.6% | 137,524 | -1.8% | 0.00% | 0.0% |
Q1 2019 | $1,706,000 | +55.4% | 140,100 | +45.3% | 0.00% | +33.3% |
Q4 2018 | $1,098,000 | -32.2% | 96,400 | +29.2% | 0.00% | 0.0% |
Q3 2018 | $1,619,000 | +22.8% | 74,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,318,000 | -9.9% | 74,600 | +7.3% | 0.00% | -25.0% |
Q1 2018 | $1,463,000 | -29.0% | 69,500 | -45.2% | 0.00% | -42.9% |
Q1 2017 | $2,062,000 | +11.0% | 126,864 | +3.1% | 0.01% | 0.0% |
Q4 2016 | $1,858,000 | +13.2% | 123,108 | +14.4% | 0.01% | +16.7% |
Q3 2016 | $1,641,000 | – | 107,648 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |